Marzetti E, Di Lorenzo R, Calvani R, Pesce V, Landi F, Coelho-Junior H
Int J Mol Sci. 2025; 26(3).
PMID: 39940869
PMC: 11817570.
DOI: 10.3390/ijms26031100.
Chen X, Lv S, Liu J, Guan Y, Xu C, Ma X
Cells. 2025; 13(24.
PMID: 39768167
PMC: 11674045.
DOI: 10.3390/cells13242076.
Guerra San Juan I, Brunner J, Eggan K, Toonen R, Verhage M
bioRxiv. 2024; .
PMID: 39314491
PMC: 11418931.
DOI: 10.1101/2024.09.06.611684.
Santos J, Park J
Cells. 2024; 13(11.
PMID: 38891112
PMC: 11171696.
DOI: 10.3390/cells13110980.
Sprunger M, Jackrel M
Biochem Soc Trans. 2024; 52(3):961-972.
PMID: 38813817
PMC: 11209761.
DOI: 10.1042/BST20220585.
Update on recent advances in amyotrophic lateral sclerosis.
Riva N, Domi T, Pozzi L, Lunetta C, Schito P, Spinelli E
J Neurol. 2024; 271(7):4693-4723.
PMID: 38802624
PMC: 11233360.
DOI: 10.1007/s00415-024-12435-9.
Mutation of the ALS-/FTD-Associated RNA-Binding Protein FUS Affects Axonal Development.
van Tartwijk F, Wunderlich L, Mela I, Makarchuk S, Jakobs M, Qamar S
J Neurosci. 2024; 44(27.
PMID: 38692734
PMC: 7616130.
DOI: 10.1523/JNEUROSCI.2148-23.2024.
Simple models to understand complex disease: 10 years of progress from models of amyotrophic lateral sclerosis and frontotemporal lobar degeneration.
Eck R, Stair J, Kraemer B, Liachko N
Front Neurosci. 2024; 17:1300705.
PMID: 38239833
PMC: 10794587.
DOI: 10.3389/fnins.2023.1300705.
TMEM106B core deposition associates with TDP-43 pathology and is increased in risk SNP carriers for frontotemporal dementia.
Marks J, Estades Ayuso V, Carlomagno Y, Yue M, Todd T, Hao Y
Sci Transl Med. 2024; 16(730):eadf9735.
PMID: 38232138
PMC: 10841341.
DOI: 10.1126/scitranslmed.adf9735.
How neurons maintain their axons long-term: an integrated view of axon biology and pathology.
Smith G, Sweeney S, OKane C, Prokop A
Front Neurosci. 2023; 17:1236815.
PMID: 37564364
PMC: 10410161.
DOI: 10.3389/fnins.2023.1236815.
Small molecules targeting different cellular pathologies for the treatment of amyotrophic lateral sclerosis.
Elmansy M, Reidl C, Rahaman M, Ozdinler P, Silverman R
Med Res Rev. 2023; 43(6):2260-2302.
PMID: 37243319
PMC: 10592673.
DOI: 10.1002/med.21974.
Amyotrophic lateral sclerosis: translating genetic discoveries into therapies.
Akcimen F, Lopez E, Landers J, Nath A, Chio A, Chia R
Nat Rev Genet. 2023; 24(9):642-658.
PMID: 37024676
PMC: 10611979.
DOI: 10.1038/s41576-023-00592-y.
MATR3 P154S knock-in mice do not exhibit motor, muscle or neuropathologic features of ALS.
Dominick M, Houchins N, Venugopal V, Zuberi A, Lutz C, Meechooveet B
Biochem Biophys Res Commun. 2023; 645:164-172.
PMID: 36689813
PMC: 10046992.
DOI: 10.1016/j.bbrc.2023.01.032.
ALS-linked KIF5A ΔExon27 mutant causes neuronal toxicity through gain-of-function.
Pant D, Parameswaran J, Rao L, Loss I, Chilukuri G, Parlato R
EMBO Rep. 2022; 23(8):e54234.
PMID: 35735139
PMC: 9346498.
DOI: 10.15252/embr.202154234.
ALS-associated KIF5A mutations abolish autoinhibition resulting in a toxic gain of function.
Baron D, Fenton A, Saez-Atienzar S, Giampetruzzi A, Sreeram A, Shankaracharya
Cell Rep. 2022; 39(1):110598.
PMID: 35385738
PMC: 9134378.
DOI: 10.1016/j.celrep.2022.110598.
Matrin3: Disorder and ALS Pathogenesis.
Salem A, Wilson C, Rutledge B, Dilliott A, Farhan S, Choy W
Front Mol Biosci. 2022; 8:794646.
PMID: 35083279
PMC: 8784776.
DOI: 10.3389/fmolb.2021.794646.
New perspectives on cytoskeletal dysregulation and mitochondrial mislocalization in amyotrophic lateral sclerosis.
Theunissen F, West P, Brennan S, Petrovic B, Hooshmand K, Akkari P
Transl Neurodegener. 2021; 10(1):46.
PMID: 34789332
PMC: 8597313.
DOI: 10.1186/s40035-021-00272-z.
Normal levels of KIF5 but reduced KLC1 levels in both Alzheimer disease and Alzheimer disease in Down syndrome: evidence suggesting defects in anterograde transport.
Chen X, Das U, Park G, Mobley W
Alzheimers Res Ther. 2021; 13(1):59.
PMID: 33691783
PMC: 7945332.
DOI: 10.1186/s13195-021-00796-6.
Matrin 3 in neuromuscular disease: physiology and pathophysiology.
Malik A, Barmada S
JCI Insight. 2021; 6(1).
PMID: 33427209
PMC: 7821588.
DOI: 10.1172/jci.insight.143948.
Generation of two induced pluripotent stem cell (iPSC) lines from an ALS patient with simultaneous mutations in KIF5A and MATR3 genes.
Medina D, Boehringer A, Dominick M, Lorenzini I, Saez-Atienzar S, Pioro E
Stem Cell Res. 2021; 50:102141.
PMID: 33388707
PMC: 8222416.
DOI: 10.1016/j.scr.2020.102141.
